Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-22-007441)

Filing Details

Accession Number:: 0001387131-22-007441
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-07-01 16:05:23
Reporting Period:: 2022-06-29

Accepted Time:: 2022-07-01 16:05:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1430306	Tonix Pharmaceuticals Holding Corp.	TNXP	Pharmaceutical Preparations (2834)	261434750

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563420	Seth Lederman	C/O Tonix Pharmaceuticals Holding Corp 26 Main Street, Suite 101 Chatham NJ 07928	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2022-06-29	20,000	$1.71	24,235	No	4	P	Indirect	By IRA Account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By IRA Account

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	3,505	Direct
Common Stock, $0.001 Par Value	1	Indirect	By spouse
Common Stock, $0.001 Par Value	1	Indirect	By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value	1	Indirect	By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value	7	Indirect	By Lederman & Co., LLC
Common Stock, $0.001 Par Value	2	Indirect	By L&L Technologies, LLC
Common Stock, $0.001 Par Value	2	Indirect	By Targent Pharmaceuticals, LLC

Footnotes

Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022.
Reporting person may be deemed to be a control person of this entity.